167 related articles for article (PubMed ID: 32389458)
1. Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.
Sterling J; Rivera-Núñez Z; Patel HV; Farber NJ; Kim S; Radadia KD; Modi PK; Goyal S; Parikh R; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Clin Genitourin Cancer; 2020 Dec; 18(6):e643-e650. PubMed ID: 32389458
[TBL] [Abstract][Full Text] [Related]
2. Utilization and quality outcomes of cT1a, cT1b and cT2a partial nephrectomy: analysis of the national cancer database.
Fero K; Hamilton ZA; Bindayi A; Murphy JD; Derweesh IH
BJU Int; 2018 Apr; 121(4):565-574. PubMed ID: 29032581
[TBL] [Abstract][Full Text] [Related]
3. Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis.
Yanagisawa T; Mori K; Kawada T; Motlagh RS; Mostafaei H; Quhal F; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Pradere B; Miki J; Kimura T; Egawa S; Shariat SF
Urol Oncol; 2022 Jul; 40(7):315-330. PubMed ID: 35562311
[TBL] [Abstract][Full Text] [Related]
4. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
5. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.
Banegas MP; Harlan LC; Mann B; Yabroff KR
Urol Oncol; 2016 Oct; 34(10):433.e9-433.e17. PubMed ID: 27321355
[TBL] [Abstract][Full Text] [Related]
6. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
7. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
8. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
[TBL] [Abstract][Full Text] [Related]
9. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
10. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
11. Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses.
Borghesi M; Schiavina R; Gan M; Novara G; Mottrie A; Ficarra V
World J Urol; 2013 Jun; 31(3):499-504. PubMed ID: 23645411
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy.
Tan WS; Koelker M; Campain N; Cole AP; Labban M; Mossanen M; Barod R; Kibel AS; Chang SL; Bex A; Trinh QD
Eur Urol Focus; 2023 Mar; 9(2):333-335. PubMed ID: 36241545
[TBL] [Abstract][Full Text] [Related]
13. Practice patterns for the surgical treatment of T1 renal cell carcinoma: a nationwide population-based register study.
Ljungberg B; Gudmundsson E; Christensen S; Lundstam S;
Scand J Urol; 2014 Oct; 48(5):445-52. PubMed ID: 24666103
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinoma.
Wu X; Uhlig J; Shuch BM; Uhlig A; Kim HS
Eur Radiol; 2023 Mar; 33(3):1801-1811. PubMed ID: 36329348
[TBL] [Abstract][Full Text] [Related]
15. Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional study.
Antonelli A; Ficarra V; Bertini R; Carini M; Carmignani G; Corti S; Longo N; Martorana G; Minervini A; Mirone V; Novara G; Serni S; Simeone C; Simonato A; Siracusano S; Volpe A; Zattoni F; Cunico SC;
BJU Int; 2012 Apr; 109(7):1013-8. PubMed ID: 21883829
[TBL] [Abstract][Full Text] [Related]
16. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
17. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
18. Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively-maintained database.
Chen K; Lee A; Huang HH; Tay KJ; Sim A; Lee LS; Cheng CWS; Ng LG; Ho HSS; Yuen JSP
Int J Urol; 2019 Apr; 26(4):465-474. PubMed ID: 30818418
[TBL] [Abstract][Full Text] [Related]
19. Robot-assisted partial nephrectomy for large renal masses: a multi-institutional series.
Delto JC; Paulucci D; Helbig MW; Badani KK; Eun D; Porter J; Abaza R; Hemal AK; Bhandari A
BJU Int; 2018 Jun; 121(6):908-915. PubMed ID: 29357404
[TBL] [Abstract][Full Text] [Related]
20. Surgical Treatment of 4-10 cm Renal-Cell Carcinoma: A Survey of the Lions and Gazelles.
Best SL; Blute M; Lane B; Abel EJ
J Endourol; 2017 Apr; 31(S1):S43-S47. PubMed ID: 28326796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
